Detalhe da pesquisa
1.
Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma.
Oncologist
; 27(6): 432-e452, 2022 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35438782
2.
Severe Hepatotoxicity of Mithramycin Therapy Caused by Altered Expression of Hepatocellular Bile Transporters.
Mol Pharmacol
; 96(2): 158-167, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31175181
3.
A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma.
Cancer
; 125(14): 2400-2408, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30951193
4.
Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma.
Cancer Immunol Immunother
; 65(12): 1533-1544, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27714434
5.
Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.
Support Care Cancer
; 24(7): 2837-42, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26838019
6.
Chemotherapy options in castration-resistant prostate cancer.
Indian J Urol
; 32(4): 262-270, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27843207
7.
A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy.
Clin Cancer Res
; 30(1): 74-81, 2024 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37535056
8.
A Phase I Study of Capivasertib in Combination With Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer.
Clin Genitourin Cancer
; 21(2): 278-285, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36572571
9.
Incorporating radioligand therapy in clinical practice in the United States for patients with prostate cancer.
Cancer Treat Rev
; 115: 102524, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36933329
10.
SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma.
Clin Cancer Res
; 29(12): 2220-2225, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37000165
11.
Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023.
J Immunother Cancer
; 11(2)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36822667
12.
Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.
Endocr Rev
; 29(2): 234-52, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18292464
13.
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline.
J Clin Oncol
; 40(25): 2957-2995, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35728020
14.
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial.
J Immunother Cancer
; 10(4)2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35414591
15.
An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma.
Oncoimmunology
; 10(1): 1984059, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34650833
16.
Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2.
J Investig Med
; 2021 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33542072
17.
TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer.
J Clin Oncol
; 39(12): 1371-1382, 2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33617303
18.
Safety and Efficacy of Nivolumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.
Clin Genitourin Cancer
; 18(6): 469-476.e4, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32641261
19.
Safety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.
Clin Genitourin Cancer
; 18(6): 461-468.e3, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32718906
20.
Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study.
Lung Cancer
; 125: 273-281, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30429032